"10.1371_journal.pone.0087837","plos one","2014-02-04T00:00:00Z","Marina De Filette; Silke Soehle; Sebastian Ulbert; Justin Richner; Michael S Diamond; Alessandro Sinigaglia; Luisa Barzon; Stefan Roels; Julianna Lisziewicz; Orsolya Lorincz; Niek N Sanders","Laboratory of Gene Therapy, Faculty of Veterinary Sciences, Ghent University, Merelbeke, Belgium; Institute of Virology, University of Zurich, Zurich, Switzerland; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Departments of Medicine, Molecular Microbiology and Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Molecular Medicine, University of Padova, Padova, Italy; Operational Direction Interactions and Surveillance, Veterinary and Agrochemical Research Centre (CODA/CERVA), Brussels, Belgium; Genetic Immunity, Budapest, Hungary and McLean, Virginia, United States of America","Conceived and designed the experiments: MDF NNS SU MSD SS. Performed the experiments: MDF SS LB AS JR OL SR. Analyzed the data: MDF NNS SS SU MSD JL. Contributed reagents/materials/analysis tools: JL OL SU MSD. Wrote the paper: MDF NNS.","Marina De Filette, Silke Soehle, Sebastian Ulbert, Justin Richner, Michael S. Diamond, Alessandro Sinigaglia, Luisa Barzon, Stefan Roels and Niek N. Sanders have no competing interests. Julianna Lisziewicz and Orsolya Lorincz are shareholders of Genetic Immunity. Their role in the manuscript was supplying the WNV-DermaVir vaccine and critical reading of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Marina De Filette","MDF",11,FALSE,5,7,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
